New app aims to ease chemo side effect monitoring for breast cancer patients

NCT ID NCT05743686

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a smartphone app that lets breast cancer patients on oral chemotherapy report side effects and get basic advice. Hospital pharmacists were alerted when needed. The goal was to see if the app could improve monitoring and reduce phone calls. Only 28 patients took part, so results are preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
smartphone app for symptom reporting
What this could lead to
If it works, this app could help patients manage side effects better and reduce unnecessary calls to healthcare teams.
What could go wrong
This is a very small pilot study with only 28 participants and no control group, so results may not apply widely. The app's benefit on survival or quality of life is not proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • St-Sacrement Hospital

    Québec, Quebec, G1S4L8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.